Scheme

Kotak Healthcare Fund

Holds 35 companies worth ₹814 Cr in Sept 2026.

Fund house
KotakThe fund house that runs this scheme.
AUM
₹835 CrKotak Healthcare Fund's AUM at the end of 30 Sept 2026, as AMFI reports it. Up 8.8% on Aug 2026, ₹768 Cr.
Largest holding
Sun Pharmaceutical Ind LtdSun Pharmaceutical Ind Ltd is 13.2% of this scheme's NAV.
Fund manager
Abhishek BisenRuns it since 11 Dec 2023, as the fund house dates it. With Dhananjay Tikariha (co-manager).

Holdings^{(Dec 2023 – Sept 2026)}

Holdings in Sept 2026. Tick up to 2 to plot them.
Plot	35 companies ·	₹ Cr
	Sun Pharmaceutical Ind Ltd	109
	Divi s Laboratories Limited	77.1
	Molbio Diagnostics Limited	41.9
	Torrent Pharmaceuticals Limited	38.4
	Acutaas Chemicals Limited	34.4
	Max Healthcare Institute Limited	29.8
	Cipla	26.9
	Park Medi World Limited	26.1
	Gland Pharma Limited	26.1
	Yatharth Hospital And Trauma Care Services Limited	25.7
	Apollo Hospitals Enterprise Limited	24.5
	Sai Life Sciences Limited	24.4
	Laurus Labs Limited	23.8
	Mankind Pharma Limited	22.5
	Krishna Institute of Medical Science Ltd	22.4
	Marksans Pharma Limited	20.1
	Anthem Biosciences Limited	19.3
	Fortis Healthcare Limited	19.3
	Prasol Chemicals Limited	18.5
	Ajanta Pharmaceuticals Limited	16.3
	Rubicon Research Limited	16.2
	Emcure Pharmaceuticals Limited	14.6
	Aurobindo Pharma	14.2
	Sequent Scientific Limited	14.2
	Orchid Pharma Limited	13
	Corona Remedies Limited	12.6
	Innova Captab Limited	11.6
	Jubilant Ingrevia Limited	11.1
	Jubilant Life Sciences	10.3
	Rainbow Children s Medicare Limited	9.2
	Dr Lal Path Labs Limited	8.7
	Cadila Healthcare	8.7
	Metropolis Healthcare Limited	8.1
	Lupin	8.1
	Pfizer	7.4

Sun Pharmaceutical Ind Ltd
Divi s Laboratories Limited

Market value of each ticked company in Kotak Healthcare Fund, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.
Month	Sun Pharmaceutical Ind Ltd	Divi s Laboratories Limited
Sept 2025	₹60.6 Cr	₹22.8 Cr
Oct 2025	₹64.3 Cr	₹27 Cr
Nov 2025	₹69.6 Cr	₹25.9 Cr
Dec 2025	₹60.2 Cr	₹25.6 Cr
Jan 2026	₹55.8 Cr	₹27.2 Cr
Feb 2026	₹60.8 Cr	₹28.8 Cr
Mar 2026	₹61.5 Cr	₹26.8 Cr
Apr 2026	₹69.6 Cr	₹29.3 Cr
May 2026	₹72.9 Cr	₹33.3 Cr
Jun 2026	₹93.1 Cr	₹36.2 Cr
Jul 2026	₹102 Cr	₹56.4 Cr
Aug 2026	₹107 Cr	₹71 Cr
Sept 2026	₹109 Cr	₹77.1 Cr

Fig. 1.Market value of each ticked company in Kotak Healthcare Fund, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.

Allocation^{(Sept 2026)}

Market cap

		% of NAV
Large Cap	5	33.44

Mid Cap	9	19.62

Small Cap	19	38.31

Unlisted	2	7.32

Cash & others		1.31

Sectors

Companies

Fig. 2.This scheme's holdings, by market cap, by sector and by company. Hover a slice or a row; click a slice to open it.

Buying and selling, month by month^{(Oct 2025 – Sept 2026)}

Buying and selling, month by month. Change in market value since the previous month, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.

Fig. 3.Change in market value since the previous month, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.

Portfolio^{(Sept 2026)}

Every holding in Sept 2026: its shares, market value (₹ crore) and % of NAV. Month end. Source: AMC monthly portfolio disclosures. Click a column's header to sort by it.

Sun Pharmaceutical Ind Ltd	Equity	Pharmaceuticals & Biotechnology	6L	109	13.21
Divi s Laboratories Limited	Equity	Pharmaceuticals & Biotechnology	83K	77.1	9.35
Molbio Diagnostics Limited	Equity	Healthcare Equipment & Supplies	3.2L	41.9	5.08
Torrent Pharmaceuticals Limited	Equity	Pharmaceuticals & Biotechnology	80K	38.4	4.65
Acutaas Chemicals Limited	Equity	Pharmaceuticals & Biotechnology	1.05L	34.4	4.17
Max Healthcare Institute Limited	Equity	Healthcare Services	3.2L	29.8	3.61
Cipla	Equity	Pharmaceuticals & Biotechnology	2L	26.9	3.26
Park Medi World Limited	Equity	Healthcare Services	9.5L	26.1	3.17
Gland Pharma Limited	Equity	Pharmaceuticals & Biotechnology	90K	26.1	3.16
Yatharth Hospital And Trauma Care Services Limited	Equity	Healthcare Services	2.49L	25.7	3.12
Apollo Hospitals Enterprise Limited	Equity	Healthcare Services	30K	24.5	2.97
Sai Life Sciences Limited	Equity	Pharmaceuticals & Biotechnology	1.6L	24.4	2.96
Laurus Labs Limited	Equity	Pharmaceuticals & Biotechnology	1.2L	23.8	2.88
Mankind Pharma Limited	Equity	Pharmaceuticals & Biotechnology	90K	22.5	2.73
Krishna Institute of Medical Science Ltd	Equity	Healthcare Services	3L	22.4	2.71
Marksans Pharma Limited	Equity	Pharmaceuticals & Biotechnology	6.25L	20.1	2.44
Anthem Biosciences Limited	Equity	Pharmaceuticals & Biotechnology	2.25L	19.3	2.34
Fortis Healthcare Limited	Equity	Healthcare Services	2.5L	19.3	2.33
Prasol Chemicals Limited	Equity	Chemicals & Petrochemicals	2.2L	18.5	2.24
Ajanta Pharmaceuticals Limited	Equity	Pharmaceuticals & Biotechnology	45K	16.3	1.97
Rubicon Research Limited	Equity	Pharmaceuticals & Biotechnology	1L	16.2	1.96
Emcure Pharmaceuticals Limited	Equity	Pharmaceuticals & Biotechnology	75K	14.6	1.77
Aurobindo Pharma	Equity	Pharmaceuticals & Biotechnology	85K	14.2	1.72
Sequent Scientific Limited	Equity	Pharmaceuticals & Biotechnology	6L	14.2	1.71
Orchid Pharma Limited	Equity	Pharmaceuticals & Biotechnology	1.3L	13	1.57
Corona Remedies Limited	Equity	Pharmaceuticals & Biotechnology	60K	12.6	1.52
Innova Captab Limited	Equity	Pharmaceuticals & Biotechnology	1L	11.6	1.41
Jubilant Ingrevia Limited	Equity	Chemicals & Petrochemicals	1.7L	11.1	1.35
Jubilant Life Sciences	Equity	Pharmaceuticals & Biotechnology	1L	10.3	1.25
Rainbow Children s Medicare Limited	Equity	Healthcare Services	70K	9.2	1.11
Dr Lal Path Labs Limited	Equity	Healthcare Services	44K	8.7	1.06
Cadila Healthcare	Equity	Pharmaceuticals & Biotechnology	75K	8.7	1.06
Metropolis Healthcare Limited	Equity	Healthcare Services	1.5L	8.1	0.98
Lupin	Equity	Pharmaceuticals & Biotechnology	40K	8.1	0.98
Pfizer	Equity	Pharmaceuticals & Biotechnology	19K	7.4	0.89

Fig. 4.Every holding in Sept 2026: its shares, market value (₹ crore) and % of NAV. Month end. Source: AMC monthly portfolio disclosures.